Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1980 Oct;41(2):431–437.

Interactions of chrysotile asbestos fibres with the complement system.

J M Saint-Remy, P Cole
PMCID: PMC1458176  PMID: 6904360

Abstract

Type A chrysotile fibres (white asbestos) were tested in vitro for activation of the complement system. Fibres were incubated in normal human serum (NHS), factor B-depleted human serum, and normal and C4-deficient guinea-pig sera; the supernates were assayed for the remaining complement activity. Activation of the alternative pathway (AP) was shown in three ways. First, quantitative measurement of factor B; second, kinetic analysis of rabbit red blood cell lysis in whole alternative pathway (AP) and factor B lytic assays; third, qualitative measurement of C3 and factor B conversion by crossed immunoelectrophoresis. No C3 convertase activity could be demonstrated on the fibres but other possible mechanisms of AP activation are discussed. Magnesium itself is not responsible for this activation because acid-treated fibres retain this property. The early classical pathway is not involved as shown by normal whole complement activity of a factor B-depleted human serum and the absence of decrease of C4 functional activity. Knowing that complement proteins are present in pulmonary alveoli, mainly provided by cell synthesis, we suggest that complement activation in vivo may be relevant to the genesis of the chronic inflammation and fibrosis in the lung.

Full text

PDF
431

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C. Effects of silica and asbestos on cells in culture. Inhaled Part. 1970;1:437–445. [PubMed] [Google Scholar]
  2. Beck E. G., Holt P. F., Nasrallah E. T. Effects of chrysotile and acid-treated chrysotile on macrophage cultures. Br J Ind Med. 1971 Apr;28(2):179–185. doi: 10.1136/oem.28.2.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bentley C., Fries W., Brade V. Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro. Immunology. 1978 Dec;35(6):971–980. [PMC free article] [PubMed] [Google Scholar]
  4. Bianco C., Eden A., Cohn Z. A. The induction of macrophage spreading: role of coagulation factors and the complement system. J Exp Med. 1976 Dec 1;144(6):1531–1544. doi: 10.1084/jem.144.6.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brade V., Lee G. D., Nicholson A., Shin H. S., Mayer M. M. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway. J Immunol. 1973 Nov;111(5):1389–1400. [PubMed] [Google Scholar]
  6. Burger R., Bitter-Suermann D., Loos M., Hadding U. Insoluble polyanions as activators of both pathways of complement. Immunology. 1977 Dec;33(6):827–837. [PMC free article] [PubMed] [Google Scholar]
  7. Davies P., Allison A. C., Ackerman J., Butterfield A., Williams S. Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature. 1974 Oct 4;251(5474):423–425. doi: 10.1038/251423a0. [DOI] [PubMed] [Google Scholar]
  8. Davis J. M. The fibrogenic effects of mineral dusts injected into the pleural cavity of mice. Br J Exp Pathol. 1972 Apr;53(2):190–201. [PMC free article] [PubMed] [Google Scholar]
  9. Einstein L. P., Hansen P. J., Ballow M., Davis A. E., 3rd, Davis J. S., 4th, Alper C. A., Rosen F. S., Colten H. R. Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest. 1977 Nov;60(5):963–969. doi: 10.1172/JCI108876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferluga J., Schorlemmer H. U., Baptista L. C., Allison A. C. Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol. 1978 Mar;31(3):512–517. [PMC free article] [PubMed] [Google Scholar]
  11. Fine D. P. Activation of the classic and alternate complement pathways by endotoxin. J Immunol. 1974 Feb;112(2):763–769. [PubMed] [Google Scholar]
  12. Fine D. P., Marney S. R., Jr, Colley D. G., Sergent J. S., Des Prez R. M. C3 shunt activation in human serum chelated with EGTA. J Immunol. 1972 Oct;109(4):807–809. [PubMed] [Google Scholar]
  13. Götze O., Bianco C., Cohn Z. A. The induction of macrophage spreading by factor B of the properdin system. J Exp Med. 1979 Feb 1;149(2):372–386. doi: 10.1084/jem.149.2.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Harington J. S., Macnab G. M., Miller K., King P. C. Enhancement of haemolytic activity of asbestos by heat-labile factors in fresh serum. Med Lav. 1971 Apr;62(4):171–176. [PubMed] [Google Scholar]
  15. Harington J. S., Miller K., Macnab G. Hemolysis by asbestos. Environ Res. 1971 Apr;4(2):95–117. doi: 10.1016/0013-9351(71)90038-7. [DOI] [PubMed] [Google Scholar]
  16. Harington J. S., Ritchie M., King P. C., Miller K. The in-vitro effects of silica-treated hamster macrophages on collagen production by hamster fibroblasts. J Pathol. 1973 Jan;109(1):21–37. doi: 10.1002/path.1711090104. [DOI] [PubMed] [Google Scholar]
  17. Hasselbacher P. Binding of immunoglobulin and activation of complement by asbestos fibers. J Allergy Clin Immunol. 1979 Oct;64(4):294–298. doi: 10.1016/0091-6749(79)90147-7. [DOI] [PubMed] [Google Scholar]
  18. Heppleston A. G., Styles J. A. Activity of a macrophage factor in collagen formation by silica. Nature. 1967 Apr 29;214(5087):521–522. doi: 10.1038/214521a0. [DOI] [PubMed] [Google Scholar]
  19. Kagan E., Solomon A., Cochrane J. C., Beissner E. I., Gluckman J., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity. Clin Exp Immunol. 1977 May;28(2):261–267. [PMC free article] [PubMed] [Google Scholar]
  20. Kagan E., Solomon A., Cochrane J. C., Kuba P., Rocks P. H., Webster I. Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol. 1977 May;28(2):268–275. [PMC free article] [PubMed] [Google Scholar]
  21. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  22. Lai A Fat R. F., van Furth R. In vitro synthesis of some complement components (C1q, C3 and C4) by lymphoid tissues and circulating leucocytes in man. Immunology. 1975 Feb;28(2):359–368. [PMC free article] [PubMed] [Google Scholar]
  23. Lew F. T., Yukiyama Y., Waks H. S., Osler A. G. Activation of the alternative (properdin) pathway by divalent cations. J Immunol. 1975 Sep;115(3):884–888. [PubMed] [Google Scholar]
  24. Light W. G., Wei E. T. Surface charge and asbestos toxicity. Nature. 1977 Feb 10;265(5594):537–539. doi: 10.1038/265537a0. [DOI] [PubMed] [Google Scholar]
  25. Martin A., Lachmann P. J., Halbwachs L., Hobart M. J. Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry. 1976 Apr;13(4):317–324. doi: 10.1016/0019-2791(76)90341-4. [DOI] [PubMed] [Google Scholar]
  26. Medicus R. G., Schreiber R. D., Götze O., Müller-Eberhard H. J. A molecular concept of the properdin pathway. Proc Natl Acad Sci U S A. 1976 Feb;73(2):612–616. doi: 10.1073/pnas.73.2.612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Morgan A., Davies P., Wagner J. C., Berry G., Holmes A. The biological effects of magnesium-leached chrysotile asbestos. Br J Exp Pathol. 1977 Oct;58(5):465–473. [PMC free article] [PubMed] [Google Scholar]
  28. Pelfrene A. F. Magnesium and cytotoxic effects of asbestos fibers. Med Lav. 1977 Sep-Oct;68(5):349–354. [PubMed] [Google Scholar]
  29. Platts-Mills T. A., Ishizaka K. Activation of the alternate pathway of human complements by rabbit cells. J Immunol. 1974 Jul;113(1):348–358. [PubMed] [Google Scholar]
  30. Polhill R. B., Jr, Pruitt K. M., Johnston R. B., Jr Kinetic assessment of alternative complement pathway activity in a hemolytic system. I. Experimental and mathematical analyses. J Immunol. 1978 Jul;121(1):363–370. [PubMed] [Google Scholar]
  31. Pooley F. D. Electron microscope characteristics of inhaled chrysotile asbestos fibre. Br J Ind Med. 1972 Apr;29(2):146–153. doi: 10.1136/oem.29.2.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Robertson J., Caldwell J. R., Castle J. R., Waldman R. H. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions. J Immunol. 1976 Sep;117(3):900–903. [PubMed] [Google Scholar]
  33. Schorlemmer H. U., Allison A. C. Effects of activated complement components on enzyme secretion by macrophages. Immunology. 1976 Nov;31(5):781–788. [PMC free article] [PubMed] [Google Scholar]
  34. Schorlemmer H. U., Bitter-Suermann D., Allison A. C. Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology. 1977 Jun;32(6):929–940. [PMC free article] [PubMed] [Google Scholar]
  35. Tetley T. D., Hext P. M., Richards R. J., McDermott M. Chrysotile-induced asbestosis: changes in the free cell population, pulmonary surfactant and whole lung tissue of rats. Br J Exp Pathol. 1976 Oct;57(5):505–514. [PMC free article] [PubMed] [Google Scholar]
  36. Turner-Warwick M. Immunology and asbestosis. Proc R Soc Med. 1973 Sep;66(9):927–930. [PMC free article] [PubMed] [Google Scholar]
  37. Turner-Warwick M., Parkes W. R. Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J. 1970 Aug 29;3(5721):492–495. doi: 10.1136/bmj.3.5721.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wagner J. C., Berry G., Skidmore J. W., Timbrell V. The effects of the inhalation of asbestos in rats. Br J Cancer. 1974 Mar;29(3):252–269. doi: 10.1038/bjc.1974.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wilson M. R., Gaumer H. R., Salvaggio J. E. Activation of the alternative complement pathway and generation of chemotactic factors by asbestos. J Allergy Clin Immunol. 1977 Oct;60(4):218–222. doi: 10.1016/0091-6749(77)90133-6. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES